In order to investigate the potential impact of CDK9 expression on the overall survival of CRC patients, Kaplan–Meier survival estimations were generated by correlating low- and high-expression groups with patients’ clinicopathological parameters listed in Table 2. This evidence concerns the gene CDK9 and colorectal carcinoma.